Cliff Asness's DSGN Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 25,957 shares of Design Therapeutics, Inc. (DSGN) worth $276,184, representing 0.00% of the portfolio. First purchased in 2023-Q4, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in DSGN, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 19,071 shares. Largest reduction occurred in Q1 2024, reducing 44,492 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Design Therapeutics (DSGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Design Therapeutics (DSGN) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +12,227 | Add 89.05% | 25,957 | $10.64 |
| Q4 2025 | +66 | Add 0.48% | 13,730 | $9.38 |
| Q3 2025 | -15,062 | Reduce 52.43% | 13,664 | $7.53 |
| Q2 2025 | -3,014 | Reduce 9.50% | 28,726 | $3.37 |
| Q1 2025 | +1,885 | Add 6.31% | 31,740 | $3.86 |
| Q4 2024 | +19,071 | Add 176.85% | 29,855 | $6.17 |
| Q3 2024 | -299 | Reduce 2.70% | 10,784 | $5.38 |
| Q2 2024 | -665 | Reduce 5.66% | 11,083 | $3.35 |
| Q1 2024 | -44,492 | Reduce 79.11% | 11,748 | $4.03 |
| Q4 2023 | +56,240 | New Buy | 56,240 | $2.65 |
Cliff Asness's Design Therapeutics Investment FAQs
Cliff Asness first purchased Design Therapeutics, Inc. (DSGN) in Q4 2023, acquiring 56,240 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Design Therapeutics, Inc. (DSGN) for 10 quarters since Q4 2023.
Cliff Asness's largest addition to Design Therapeutics, Inc. (DSGN) was in Q4 2023, adding 56,240 shares worth $149,036.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 25,957 shares of Design Therapeutics, Inc. (DSGN), valued at approximately $276,184.
As of the Q1 2026 filing, Design Therapeutics, Inc. (DSGN) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Design Therapeutics, Inc. (DSGN) was 56,240 shares, as reported at the end of Q4 2023.